Atlas Trials

Treat and Extend Analysis Trial With Aflibercept in Wet-AMD

Clinical trial NCT04113538 · UNKNOWN

Trial details

NCT number
NCT04113538
Sponsor
Michel Giunta
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Wet Age-related Macular Degeneration
Start date
2019-07-24
Primary completion
2023-01-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.